Dr. Rebecca J. Jaslow

Claim this profile

Thomas Jefferson University Hospital

Studies Breast Cancer
Studies Cancer
2 reported clinical trials
6 drugs studied

Area of expertise

1Breast Cancer
Rebecca J. Jaslow has run 2 trials for Breast Cancer. Some of their research focus areas include:
HER2 positive
ER negative
PR negative
2Cancer
Rebecca J. Jaslow has run 1 trial for Cancer. Some of their research focus areas include:
HER2 positive
ER positive
ER negative

Affiliated Hospitals

Image of trial facility.
Thomas Jefferson University Hospital
Image of trial facility.
Trinitas Hospital And Comprehensive Cancer Center - Williamson Street Campus

Clinical Trials Rebecca J. Jaslow is currently running

Image of trial facility.

T-DM1 + Tucatinib

for Breast Cancer

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria

More about Rebecca J. Jaslow

Clinical Trial Related9 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Rebecca J. Jaslow has experience with
  • Carboplatin
  • Cyclophosphamide
  • Doxorubicin Hydrochloride
  • Paclitaxel
  • Trastuzumab Emtansine
  • Tucatinib
Breakdown of trials Rebecca J. Jaslow has run
Breast Cancer
Cancer

Other Doctors you might be interested in

Mark D. HurwitzThomas Jefferson University Hospital
Shridar GanesanRutgers Cancer Institute of New Jersey
Sarah W. Gordon, DOVirginia Commonwealth University

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rebecca J. Jaslow specialize in?
Rebecca J. Jaslow focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER negative.
Is Rebecca J. Jaslow currently recruiting for clinical trials?
Yes, Rebecca J. Jaslow is currently recruiting for 1 clinical trial in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Rebecca J. Jaslow has studied deeply?
Yes, Rebecca J. Jaslow has studied treatments such as Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride.
What is the best way to schedule an appointment with Rebecca J. Jaslow?
Apply for one of the trials that Rebecca J. Jaslow is conducting.
What is the office address of Rebecca J. Jaslow?
The office of Rebecca J. Jaslow is located at: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107 United States. This is the address for their practice at the Thomas Jefferson University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top